Glucosum 5% et Natrium chloratum 0.9% 2: 1 Fresenius
Glucosum 5% et Natrium chloratum 0.9% 2: 1 Fresenius, Fresenius Kabi
indications:
Hypertonic or isotonic drainage. Parenteral supplementation of liquids, carbohydrates and electrolytes (sodium, chlorine), when the supply is different than intravenous (especially in pediatrics). For the dilution and dissolution of electrolyte concentrates and non-incompatible preparations.
Composition:
100 ml of liquid contains 3.33 g of Glucose and 300 mg of sodium chloride.
Action:
A solution of glucose and sodium chloride - a source of carbohydrates, electrolytes and water. Glucose is also an easily accessible source of energy. Oxidized to carbon dioxide excreted through the lungs and water excreted by the kidneys. Sodium chloride is the main component of extracellular fluid, it is excreted mainly by the kidneys. Osmolarity 290 mosmol / l; pH 3.5-6.5.
Contraindications:
Conduction, hypernatremia, hypokalemia, hyperchloremia, hyperglycemia, acidosis. Heart failure, generalized swelling, pulmonary edema, hypertension, eclampsia or severe renal failure. The product should not be administered with blood through the same transfusion set (pseudo-agglutination of blood cells).
Precautions:
Extremely cautious (if there is a strong need for administration), it should be used in patients with congestive heart failure, severe renal failure or edema with sodium retention. Carefully used in patients with diabetes mellitus and patients treated with corticosteroids and corticotropin.
Pregnancy and lactation:
Solutions containing glucose should be used with caution in pregnancy due to the risk of hyperglycaemia, hyperinsulinemia and fetal acidosis and hypoglycaemia in the newborn. In pregnant and breastfeeding women, give the dose, contraindications and precautionary recommendations and restrictions.
Side effects:
The following may occur: fever, infection at the injection site, venous thrombosis or phlebitis spreading from the injection site, extravasation and hypervolaemia (indications for immediate interruption of the infusion). If the infusion rate is greater than 15 ml / kg / h, hyperglycemia and glucosuria may occur. During long-term treatment fluid balance, acid-base balance, electrolyte depression (hypokalemia, hypomagnesaemia, hypophosphatemia), peripheral edema may occur. In patients with cardiovascular disease, excessive supply of the preparation may increase heart failure and cause pulmonary edema. Patients with impaired renal function may experience sodium retention.
Dosage:
Intravenous drip infusion. Individual dosage, depending on the demand, age, condition of the patient and the loss of fluid and current electrolyte concentration. The maximum dose is 0.5 g glucose / kg / h. Can be given to peripheral veins: choose the vein of the arm and change the injection site every day.
(C)
